当前位置: X-MOL 学术Antivir. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2017-10-31 , DOI: 10.3851/imp3158
Clément Fage 1 , Véronique Tu 1 , Julie Carbonneau 1 , Yacine Abed 1 , Guy Boivin 1
Affiliation  

Peramivir is a parenteral neuraminidase inhibitor (NAI) approved for treating influenza infections in a few countries. We determined peramivir susceptibilities of several uncharacterized influenza A and B neuraminidase (NA) and haemagglutinin (HA) mutants selected with different NAIs.

中文翻译:

用各种神经氨酸酶抑制剂选择的重组甲型和乙型流感病毒的帕拉米韦敏感性。

Peramivir是一种肠胃外神经氨酸酶抑制剂(NAI),已在一些国家/地区批准用于治疗流感感染。我们确定了几种用不同NAI选择的未表征的甲型和乙型流感神经氨酸酶(NA)和血凝素(HA)突变体的帕拉米韦敏感性。
更新日期:2020-08-21
down
wechat
bug